TrialDrugs2021

Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2).

Jason Bacharach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.